December 5, 2020         
Entravision Raises Over $2.2 Million for Children’s Miracle Network Hospitals   •   Web Summit: With funding from Apple, Malala Fund is conducting research to look at the impacts of climate change on girls and yo   •   Ulta Beauty Announces Third Quarter Fiscal 2020 Results   •   Fuze Wins 2020 Aragon Research Women in Technology Award for Public Relations   •   Mary Alexander Selected to Daily Journal's Top 100 Attorneys List and Top Women Lawyers List   •   AEO Updates Payment of Deferred First Quarter Cash Dividend of $0.1375 Per Share, Due to Strong Financial Condition   •   New Studies Call Attention to Effects of Structural Inequities on Health in America   •   New Study Finds Once Hospitalized, Black Patients with COVID-19 Have Lower Risk of Death than White Patients   •   December 6: Remember and Work for Change   •   St. Joseph's Children's Hospital First Hospital in West Central Florida to Implant New Device to Repair Life-Threatening Heart D   •   nTIDE November 2020 Jobs Report: Americans with Disabilities Remain Engaged in Labor Force   •   Japanese Lawmakers Call for International Agreement to Prohibit the Eating of Dogs and Cats   •   CURE Media Group Announces the 2020 MPN Heroes® Winners   •   Hall of Fame Resort & Entertainment Company Announces Closing of Underwriters’ Option to Purchase Additional Shares of   •   Communitech’s Fierce Founders Uplift: Levelling the Playing Field and Shattering Glass Ceilings   •   Top Universal Studios Execs Testimony Demanded in Lawsuit Over Racist Treatment of Black Star Faizon Love, BRG Lawsuit Claims   •   Desert Financial to Match $20 K in Donations to Phoenix Children's Hospital   •   Children’s Hospital Los Angeles Offers FREE Flu Vaccination Family Clinic   •   The Elves Are Flying Off the Shelf - The Elf on the Shelf® and Elf Pets® Are Scarce but Can Still Be Found in Select Loc   •   Ric Edelman Shares the Post-Election Investment Strategy You Need Now
Bookmark and Share

UCLA Begins Recruitment For Phase 3 Of The Oxford University - AstraZeneca COVID-19 Vaccine Trial

UCLA Begins Recruitment For Phase 3 Of The Oxford University - AstraZeneca COVID-19 Vaccine Trial

Prospective volunteers can now sign-up to participate in the trial

PR Newswire

LOS ANGELES, Oct. 29, 2020 /PRNewswire/ -- Recruitment is underway for volunteers for the phase 3 trial of the Oxford University – AstraZeneca COVID-19 vaccine at UCLA Health which joins other medical centers nationwide as part of the study effort .

The vaccine, developed by Oxford University and AstraZeneca, is called AZD1222 and has successfully gone through earlier smaller phase 1 and 2 trials. The phase 3 trial is designed to determine whether two doses of the vaccine can prevent symptomatic COVID-19. The study aims to enroll 30,000 volunteers across the United States and more than 250 at UCLA. 

This vaccine does not contain a live SARS-CoV-2 virus and cannot give a person COVID-19. If the results from the trial are positive, the vaccine could be made available to the public to prevent disease. 

Recruitment for the trial has resumed following a brief pause after the FDA, the independent Data and Safety Monitoring Board, and AstraZeneca reviewed a possible adverse reaction seen in a trial participant in the United Kingdom. The FDA and independent regulators reviewed all safety data from trials globally (around 18,000 participants) and concluded it is safe to resume the phase 3 trial. It is not unusual that in large scale phase 3 trials, some participants will become unwell, and every case has to be evaluated to ensure the careful assessment of safety.  

"The safety of our volunteers and participants is the first priority of everyone working on this trial across the nation and locally here in Los Angeles," said Dr. Raphael Landovitz, the trial's lead researcher at UCLA and co-director of UCLA's Center for HIV Identification, Prevention and Treatment Services.  "Having a safe and effective vaccine is critical to ending the pandemic. We are looking forward to getting this trial underway so that we can find a vaccine for everyone, and especially those that have been most impacted by COVID-19. Help Stop COVID LA is an opportunity for the Los Angeles community to be a part of the solution to help end this pandemic.  We hope everyone who is at risk for COVID-19 or its complications will consider if volunteering for this trial is right for them."

To be eligible, a volunteer cannot have previously tested positive for COVID-19. Volunteers are assigned at random to receive the investigational vaccine or a placebo (saline injection). The trial is blinded, meaning the participants and the investigators will not know who receives the vaccine. Of the volunteers enrolled, two-thirds will get the study vaccine and one-third will get a placebo or harmless injection. This allows researchers to compare outcomes in the vaccine group against the placebo group. In the two years that follow, researchers will monitor all study volunteers for the development of symptomatic COVID-19 and for any side effects of the vaccine.

UCLA is part of the COVID-19 Prevention Network (CoVPN) participating in the phase 3 trial. The network, supported by the National Institute of Allergy and Infectious Diseases (NIAID), aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.

UCLA is recruiting volunteers who reside in the greater Los Angeles area, primarily including members of the Black, Latinx, Asian/Pacific Islander, and Native American communities that have been disproportionately affected by COVID-19 and are at  high-risk for severe disease. This also includes:

  • Persons over 55 years of age;
  • Persons with preexisting medical conditions including high blood pressure, diabetes and obesity;
  • Essential and front-line workers throughout the pandemic.

To find out more and sign up to volunteer please visit www.helpstopcovid.la

Cision View original content:http://www.prnewswire.com/news-releases/ucla-begins-recruitment-for-phase-3-of-the-oxford-university--astrazeneca-covid-19-vaccine-trial-301163335.html

SOURCE UCLA Health



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News